SO
Sartorius Aktiengesellschaft
SOAGY · OTC
$57.65 +1.21% (+$0.69)
1M +0.23%
Market Cap 73.5B €
P/E Ratio 373.58x
Div. Yield 0.30%
ROE 7.19%
Bulios Fair Price
$51.05
11.4% downside
Current Price
$57.65
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SOAGY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
0 /100
Expensive P/E 373.58x
PEG 6.40x
EV/EBITDA 73.82x
Growth
14 /100
Declining EPS growth 45.59%
Book val. growth 10.79%
Rev. growth 6.63%
Profitability
65 /100
Moderate Gross margin 45.72%
FCF margin 8.54%
Net margin 5.48%
Quality
28 /100
Poor ROIC 5.01%
Asset turnover 0.37x
ROE 7.19%
Debt
36 /100
Moderate Debt/Equity 1.44x
Net debt/EBITDA 3.60x
Current ratio 1.14x
Stability
49 /100
Moderate Beta 1.52x
Profitable years 6
Rev. volatility 10.81%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SOAGY
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Michael Grosse
Employees
14,042
Headquarters
Göttingen